Sign inJoin waitlistJoin the waitlist

JO

Joseph Oved

Attending Physician, Division of Hematology, Children's Hospital of Philadelphia · Stanford Health Care

Credentials: · · · · ·

History

Stanford Health Care
Present

Hematology and Medical Oncology
2016–2019
Pediatrics
New York Presbyterian Hospital
2013–2016
New York University Grossman School of Medicine
2009–2013

Research

STAT3-BDNF-TrkB signalling promotes alveolar epithelial regeneration after lung injury
Nature Cell Biology · 2020 · 111 citations
Cellular therapy: Immune-related complications
Review · Immunological Reviews · 2019 · First of 3 authors · 58 citations
Self-organization of the hematopoietic vascular niche and emergent innate immunity on a chip
Cell stem cell · 2024 · 29 citations

Susan Prockop
14 papers
Timothy Olson
12 papers
JB
Jaap-Jan Boelens
10 papers
Richard O’Reilly
10 papers
AS
Andromachi Scaradavou
7 papers
Barbara Spitzer
7 papers
DC
Deepakbabu Chellapandian
7 papers
JL
Jennifer Leiding
7 papers
KC
Kevin Curran
7 papers
Rebecca Marsh
7 papers
Ami Shah
6 papers
Caridad Martinez
6 papers

Grants

Phase 2a/2b Study Emapalumab: A Window of Opportunity in Pediatric Aplastic Anemia
Food and Drug Administration · R01
Contact PI · $1.3M · Columbia University Health Sciences
2024–2028
Phase 2 Bridging Pre-Transplant Inflammatory Dampening for Primary Immune Regulatory Disorders (BRIDGE Trial)
Food and Drug Administration · R01
Contact PI · $1.9M · Columbia University Health Sciences
2023–2028

Clinical trials

A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
Principal investigator · Recruiting · Phase 2
Joseph Oved
2023–2027
JSP191 Antibody Targeting Conditioning in SCID Patients
Principal investigator · Terminated · Phase 1, Phase 2
Jasper Therapeutics, Inc.
2017–2025
Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations
Site PI · Not yet recruiting · Phase 1, Phase 2
Lisa Satter
2026–2028